NPC's John O'Brien to Speak at GW Drug Pricing Policy & Law Symposium

NPC President and CEO John O’Brien will participate in the George Washington University Drug Pricing Policy and Law Symposium, which will cover  “A Preliminary Assessment of the IRA’s Drug Price Provisions.” The symposium will take place from 8:30 AM – 3:00 PM ET, and Dr. O’Brien will join a lunch panel session titled “A Step Back to Determine What We Want to Achieve.” Noam Levey of KFF Health News will moderate the conversation between Dr. O’Brien, Richard Frank of The Brookings Institution at Harvard Medical School, and Sarah Emond of the Institute for Clinical and Economic Review (ICER). 

Join GW's Health Law and Policy Program for this timely, one-day convening of scholars, policymakers, advocates, and industry stakeholders to examine the early implementation of the Inflation Reduction Act's drug pricing provisions and celebrate the anniversary of Medicare Part D. 

This event is open to the public and media. Learn more here, and then register to attend here.